Riegel_v._Medtronic,_Inc.

<i>Riegel v. Medtronic, Inc.</i>

Riegel v. Medtronic, Inc.

2008 United States Supreme Court case

Riegel v. Medtronic, Inc., 552 U.S. 312 (2008), is a United States Supreme Court case in which the Court held that the pre-emption clause of the Medical Device Amendment bars state common-law claims that challenge the effectiveness or safety of a medical device marketed in a form that received premarket approval from the Food and Drug Administration.[1]

Quick Facts Riegel v. Medtronic, Inc., Argued December 4, 2007 Decided February 20, 2008 ...

It modified the rule in Medtronic, Inc. v. Lohr.[2]

See also

References

  1. [1]
    Riegel v. Medtronic, Inc., 552 U.S. 312 (2008).
  2. [2]
    Medtronic, Inc. v. Lohr, 518 U.S. 470 (1996).

Further reading

  • Korobkin, Russell (2007). "Who Should Protect the Public? The Supreme Court and Medical Device Regulation". New England Journal of Medicine. 357 (17): 1680–1681. doi:10.1056/NEJMp078142. PMID 17960010.


Stub icon

This article related to the Supreme Court of the United States is a stub. You can help Wikipedia by expanding it.
Share this article:

This article uses material from the Wikipedia article Riegel_v._Medtronic,_Inc., and is written by contributors. Text is available under a CC BY-SA 4.0 International License; additional terms may apply. Images, videos and audio are available under their respective licenses.